K. Jung

发表

Engineering of anti-human interleukin-4 receptor alpha antibodies with potent antagonistic activity

Yong-Sung Kim, Hae‐Sim Park, Seung-Hyun Kim, 2019, Scientific Reports.

Antibody-mediated delivery of a viral MHC-I epitope into the cytosol of target tumor cells repurposes virus-specific CD8+ T cells for cancer immunotherapy

Yong-Sung Kim, K. Jung, Jeong-Ah Kim, 2022, Molecular cancer.

Emerging Co-signaling Networks in T Cell Immune Regulation

I. Choi, K. Jung, 2013, Immune network.

A Neuropilin-1 Antagonist Exerts Antitumor Immunity by Inhibiting the Suppressive Function of Intratumoral Regulatory T Cells

Yong-Sung Kim, K. Jung, Jeong-Ah Kim, 2019, Cancer Immunology Research.

Knockdown of the interleukin-6 receptor alpha chain of dendritic cell vaccines enhances the therapeutic potential against IL-6 producing tumors.

Tae Woo Kim, I. Choi, K. Jung, 2010, Vaccine.

Engineering of Humanized Antibodies Against Human Interleukin 5 Receptor Alpha Subunit That Cause Potent Antibody-Dependent Cell-Mediated Cytotoxicity

Yong-Sung Kim, Hae‐Sim Park, Jungeun Kim, 2021, Frontiers in Immunology.

VSIG4-expressing tumor-associated macrophages impair anti-tumor immunity.

B. Bogen, I. Choi, J. Byun, 2022, Biochemical and biophysical research communications.

Programmed death-1 receptor negatively regulates LPS-mediated IL-12 production and differentiation of murine macrophage RAW264.7 cells.

I. Choi, Soo‐Woong Lee, I. Choi, 2009, Immunology letters.

Endogenous VSIG4 negatively regulates the helper T cell-mediated antibody response.

I. Choi, S. Seo, K. Jung, 2015, Immunology letters.

Protective role of V‐set and immunoglobulin domain‐containing 4 expressed on kupffer cells during immune‐mediated liver injury by inducing tolerance of liver T‐ and natural killer T‐cells

I. Choi, S. Seo, C. Park, 2012, Hepatology.

Affinity Maturation of a T-Cell Receptor-Like Antibody Specific for a Cytomegalovirus pp65-Derived Peptide Presented by HLA-A*02:01

Yong-Sung Kim, K. Jung, Jeong-Ah Kim, 2021, International journal of molecular sciences.

Improved intratumoral penetration of IL12 immunocytokine enhances the antitumor efficacy

Yong-Sung Kim, K. Jung, So-Yeol Yoo, 2022, Frontiers in Immunology.

Tumor cells loaded with α-galactosylceramide promote therapeutic NKT-dependent anti-tumor immunity in multiple myeloma.

Hyunkeun Song, Sungyoul Hong, B. Bogen, 2013, Immunology letters.

Antibody targeting intracellular oncogenic Ras mutants exerts anti-tumour effects after systemic administration

S. Shin, Yong-Sung Kim, Ji-sun Kim, 2017, Nature Communications.

Heterodimeric Fc-fused IL12 shows potent antitumor activity by generating memory CD8+ T cells

Yong-Sung Kim, J. Ha, Chul-Ho Kim, 2018, Oncoimmunology.

Knockdown of the interleukin-6 receptor alpha chain of dendritic cell vaccines enhances the therapeutic potential against IL-6 producing tumors.

Tae Woo Kim, I. Choi, K. Jung, 2010, Vaccine.